NeoVanc: New study finds no clear benefit from a shorter optimised vancomycin treatment in babies with Gram positive late onset sepsis
🇬🇧 NeoVanc: New study finds no clear benefit from a shorter optimised vancomycin treatment in babies with Gram positive late onset sepsis
Public consultation on the draft WHO Essential Medicines List Antibiotic Book
In Memory of Dr Scott M. Hammer
🇬🇧 VERDI project launches
